After 55% Rise, Is Regeneron Stock Poised To Decline?

Biotech company Regeneron has seen its stock price rally by over 55% this year with the stock currently trading at about $600 per share, due to anticipation surrounding the company's experimental Covid treatments. Regeneron has gotten a lot of attention in recent weeks, amid news that...